BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32343284)

  • 1. Pharmacological agents to treat severe neuropsychiatric symptoms in major neurocognitive disorders.
    Mischel N; Rakesh G; Gupta S; Muzyk A; Masand P
    Ann Clin Psychiatry; 2020 May; 32(2):128-141. PubMed ID: 32343284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Therapy for Behavioral and Psychological Symptoms of Dementia.
    Wang F; Feng TY; Yang S; Preter M; Zhou JN; Wang XP
    Curr Neuropharmacol; 2016; 14(4):307-13. PubMed ID: 26644152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Behavioral and Psychological Symptoms of Dementia.
    Bessey LJ; Walaszek A
    Curr Psychiatry Rep; 2019 Jul; 21(8):66. PubMed ID: 31264056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of behavioral and psychological symptoms of dementia: a systematic review.
    Preuss UW; Wong JW; Koller G
    Psychiatr Pol; 2016; 50(4):679-715. PubMed ID: 27847922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature.
    Ozkan B; Wilkins K; Muralee S; Tampi RR
    Am J Alzheimers Dis Other Demen; 2008; 23(4):344-54. PubMed ID: 18509106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsants for behavioral and psychological symptoms in dementia: protocol for a systematic review.
    Benjamin S; Williams JW; Cotton C; Tung J; An H; Sanger S; Ho JM
    Syst Rev; 2019 May; 8(1):118. PubMed ID: 31103045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.
    Okumura Y; Togo T; Fujita J
    Int Psychogeriatr; 2015 Mar; 27(3):407-15. PubMed ID: 25213318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of sedating antidepressants, antipsychotics, and anticonvulsants in the management of insomnia?
    McCall C; McCall WV
    Curr Psychiatry Rep; 2012 Oct; 14(5):494-502. PubMed ID: 22923053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.
    Hemels ME; Lanctôt KL; Iskedjian M; Einarson TR
    Drugs Aging; 2001; 18(7):527-50. PubMed ID: 11482746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis.
    Watt JA; Goodarzi Z; Veroniki AA; Nincic V; Khan PA; Ghassemi M; Thompson Y; Lai Y; Treister V; Tricco AC; Straus SE
    BMC Geriatr; 2020 Jun; 20(1):212. PubMed ID: 32546202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacological treatment of elderly demented patients.
    Small GW
    J Clin Psychiatry; 1988 May; 49 Suppl():8-13. PubMed ID: 2897357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Sink KM; Holden KF; Yaffe K
    JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicines management for people with dementia.
    Mitchell G; Rooney S; Sheeran C; Strain J
    Nurs Stand; 2019 Feb; 34(3):37-43. PubMed ID: 31468925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic and Bipolar Disorders: Behavioral Disorders in Dementia.
    Morgan S
    FP Essent; 2017 Apr; 455():18-22. PubMed ID: 28437057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends in antipsychotic drug use in patients with dementia: a nationwide study.
    Nørgaard A; Jensen-Dahm C; Gasse C; Hansen HV; Waldemar G
    J Alzheimers Dis; 2016; 49(1):211-20. PubMed ID: 26444790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.
    Maust DT; Langa KM; Blow FC; Kales HC
    Int J Geriatr Psychiatry; 2017 Feb; 32(2):164-174. PubMed ID: 26889640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Care Physician Perspectives about Antipsychotics and Other Medications for Symptoms of Dementia.
    Kerns JW; Winter JD; Winter KM; Boyd T; Etz RS
    J Am Board Fam Med; 2018; 31(1):9-21. PubMed ID: 29330235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.